GV Therapeutics a prominent biotechnology company at the forefront of integrating AI genomics and disease biology has made a significant announcement Theyve partnered with Merck
Aspen Neuroscience Inc recently announced a significant milestone in Parkinsons disease treatment
Medincell has announced a collaboration with AbbVie to jointly develop and commercialize up to six therapeutic products across various therapeutic areas and indications The partnership aims to utilize
NMDP BioTherapies formerly Be The Match BioTherapies has recently announced significant upgrades to its cellular starting material offerings including the addition of a Drug Master File
Spinogenix Inc a company specializing in developing innovative therapies aimed at restoring synaptic function to enhance the lives of patients worldwide has received clearance from the US Food and Drug
AviadoBio a pioneering gene therapy company dedicated to developing transformative medicines for neurodegenerative disorders has recently initiated the Phase ASPIREFTD trial This trial
Genentech a member of the Roche Group announced today that the US Food and Drug Administration has approved Alecensa for adjuvant treatment following
Psyence Biomedical Ltd today announced that details of its upcoming Phase IIb clinical trial of naturederived psilocybin in patients diagnosed with Adjustment Disorder following an advanced cancer diagnosis in the Palliative Care context
Ventus Therapeutics a clinicalstage biopharmaceutical company utilizing its proprietary structural biology and computational chemistry platform ReSOLVE
CancerVax Inc the developer of breakthrough cancer drugs that will use the bodys immune system to fight cancer today announced that its UCLA research team has created a promising new drug candidate for treating recurrent
Tokyo, Japan
Munich, Germany
Berlin, Germany
Boston, MA, USA
Vienna, Austria
London, UK
Jakarta, Indonesia
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Gene therapy has emerged as a promising approach for treating a wide range of genetic disorders and diseases by introducing genetic material into cells to correct or replace abnormal genes In vitro gene therapies conducted in controlled laboratory settings
Hot Melt Extrusion has emerged as a cuttingedge technology in the field of pharmaceutical formulation offering a range of innovative techniques to improve drug delivery and enhance therapeutic outcomes
In the constantly evolving field of drug discovery a new era is on the horizon Artificial Intelligence has emerged as a gamechanger revolutionizing the way drugs are developed AIpowered platforms are dramatically
In the everevolving landscape of drug development advancements in Central Nervous System treatments have taken center stage From mental health disorders to neurodegenerative diseases pharmaceutical companies
In the everevolving world of pharmaceuticals staying at the cutting edge of technology is paramount Enter mass spectrometry a transformative technique revolutionizing drug development and analysis
In the exciting realm of gene therapy vector manufacturing plays a vital role in bringing hope to countless individuals By utilizing genecarrying vectors scientists and researchers can target and correct
An overarching aim of neuroscience is to build quantitatively accurate computational models of sensory systems Success entails models that take sensory signals as input and reproduce the behavioral judgments mediated by a sensory system as well as its internal representations
Pfizer has just received accelerated approval from the US Food and Drug Administration FDA for its ELREXFIO elranatamabbcmm to treat adult patients dealing with relapsed or refractory multiple myeloma RRMM
Determining the ability of a target to bind to a drug with high affinity to modulate its function with a therapeutic benefit could be termed Druggability It needs a nontrivial amount of time financial investment
Navigating the complex and dynamic gene therapy regulatory landscape has been a persistent challenge for developers and manufacturers
Antibody drug conjugates ADCs are innovative modalities to deliver chemotherapeutics to specifically targeted populations of cancer cells
Clinical trials form the backbone of pharmaceutical development acting as the proving ground where the safety and efficacy of novel medical interventions are thoroughly evaluated
A number of exciting innovations have begun to gain the attention of companies within the pharmaceutical sector Artificial intelligence AI
The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues
EBR systems are more reliable and compliance than traditional paper documents log in measures